Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Total Current Liabilities (2016 - 2026)

Standard Biotools has reported Total Current Liabilities over the past 16 years, most recently at $108.3 million for Q4 2025.

  • Quarterly Total Current Liabilities rose 64.36% to $108.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $108.3 million through Dec 2025, up 64.36% year-over-year, with the annual reading at $108.3 million for FY2025, 64.36% up from the prior year.
  • Total Current Liabilities was $108.3 million for Q4 2025 at Standard Biotools, roughly flat from $108.0 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $123.8 million in Q2 2024 and troughed at $42.8 million in Q2 2022.
  • The 5-year median for Total Current Liabilities is $53.2 million (2021), against an average of $71.8 million.
  • Year-over-year, Total Current Liabilities soared 177.6% in 2024 and then tumbled 53.74% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $49.6 million in 2021, then decreased by 12.36% to $43.4 million in 2022, then skyrocketed by 151.66% to $109.3 million in 2023, then crashed by 39.73% to $65.9 million in 2024, then soared by 64.36% to $108.3 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Total Current Liabilities are $108.3 million (Q4 2025), $108.0 million (Q3 2025), and $98.0 million (Q2 2025).